Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,499 citations, 2005 year and bronze oa status.
1,499
Citations
2005
Year
bronze
OA Status